Open Now
Contact Information
18-22 South 6th Street , Allentown, Pennsylvania 18101, United States
Detailed Information
Treatment Trends Inc Allentown Residential
-
Services:
- Cash or self-payment
- Federal, or any government funding for substance use treatment programs
- Medicaid
- Prescribes buprenorphine
- Buprenorphine maintenance
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Housing services
- Self-help groups
- Recovery coach
- Mentoring/peer support
- Assistance with obtaining social services
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Private non-profit organization
- Relapse prevention
- Motivational interviewing
- Anger management
- Trauma-related counseling
- Contingency management/motivational incentives
- Matrix Model
- Cognitive behavioral therapy
- 12-step facilitation
- Substance use disorder counseling
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Comprehensive mental health assessment
- Complete medical history/physical exam
- Screening for tobacco use
- Comprehensive substance use assessment
- Mental health services
- Case management service
- Social skills development
- Transportation assistance
- STD testing
- Testing for Hepatitis C (HCV)
- Metabolic syndrome monitoring
- HIV testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis B (HBV)
- Drug or alcohol urine screening
- TB screening
- Individual counseling
- Marital/couples counseling
- Health education services other than HIV/AIDS or hepatitis
- Smoking/vaping/tobacco cessation counseling
- Substance use disorder education
- Family counseling
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Group counseling
- In-network prescribing entity
- Other contracted prescribing entity
- Aftercare/continuing care
- Outcome follow-up after discharge
- Discharge Planning
- Naloxone and overdose education
- State Substance use treatment agency
- State department of health
- Smoking permitted in designated area
- Female
- Male
- Substance use treatment
- Vaping not permitted
- Acamprosate (CampralĀ®)
- Buprenorphine with naloxone
- Disulfiram
- Non-nicotine smoking/tobacco cessation
- Buprenorphine without naloxone
- Clonidine
- Naltrexone (oral)
- Buprenorphine (extended-release, injectable)
- Medications for HIV treatment
- Lofexidine
- Medication for mental disorders
- Naltrexone (extended-release, injectable)
- Nicotine replacement
- Medications for Hepatitis C treatment
- Young Adults
- Adults
- In-network prescribing entity
- Other contracted prescribing entity
- Short-term residential
- Residential/24-hour residential
- Long-term residential
- Clients with co-occurring mental and substance use disorders
- Criminal justice (other than DUI/DWI)/Forensic clients
- Adult men
Payment/Insurance/Funding Accepted
Type of Opioid Treatment
Recovery Support Services
Opioid Medications used in Treatment
Facility Operation (e.g., Private, Public)
Treatment Approaches
Type of Alcohol Use Disorder Treatment
Assessment/Pre-treatment
Ancillary Services
Testing
Education and Counseling Services
External Opioid Medications Source
Transitional Services
License/Certification/Accreditation
Facility Smoking Policy
Gender Accepted
Type of Care
Facility Vaping Policy
Pharmacotherapies
Age Groups Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Special Programs/Groups Offered
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm